The prediction and long-term maintenance of low disease activity during therapy with disease modifying anti-inflammatory drugs for rheumatoid arthritis
Therapy with biological agents (biologics) over the past few years has become an important part of the strategy of medical treatment of patients with rheumatoid arthritis who respond insufficiently to the disease modifying anti-inflammatory drugs. The possibility to predict response to biologics is...
Main Author: | E.L. Luchikhina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2014-05-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/551 |
Similar Items
-
EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION
by: I. G. Kirillova, et al.
Published: (2015-09-01) -
The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease
by: N. V. Chichasova
Published: (2015-12-01) -
Tofacitinib in baseline treatment of rheumatoid arthritis: own clinical experience
by: A. R. Babaeva, et al.
Published: (2016-12-01) -
The role of etanercept in the treatment of patients with severe rheumatoid arthritis
by: N. V. Chichasova
Published: (2013-12-01) -
Kinase inhibitors in rheumatoid arthritis: reality and prospects
by: D. Е. Karateyev
Published: (2013-12-01)